Rare diseases
Investigational molecules
Locations
Back to Czechia47 clinical trials in Jihlava, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)CzechiaStudy on the Effects of Obexelimab for Patients with Relapsing Multiple Sclerosis
CzechiaStudy of dapagliflozin effects in patients hospitalized with acute heart failure
CzechiaStudy on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Patients with Asthma
CzechiaStudy on the Effects of Verekitug (UPB-101) for Adults with Severe Asthma
CzechiaStudy Comparing Subcutaneous and Intravenous Ocrelizumab for Patients with Multiple Sclerosis
CzechiaStudy on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis
CzechiaStudy on the Safety and Effectiveness of Diamyd and Colecalciferol for Adolescents and Adults with Recently Diagnosed Type 1 Diabetes
CzechiaStudy on Frexalimab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients Aged 12-21 on Insulin Therapy
CzechiaStudy on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
CzechiaStudy on the Safety and Efficacy of BIIB091 and Diroximel Fumarate for Patients with Relapsing Multiple Sclerosis
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on multiple sclerosis treatments, including studies of novel therapies like frexalimab and comparative analyses of established medications. Clinical trials are evaluating both relapsing and progressive forms of MS, with emphasis on long-term efficacy and safety.
Several trials are investigating new delivery methods and formulations to improve patient outcomes.
Innovative studies targeting cardiovascular diseases, including trials for heart failure, myocardial infarction, and stroke prevention. Research includes evaluation of new compounds for reducing cardiovascular events and improving patient outcomes.
Focus on both preventive measures and acute treatment strategies for cardiovascular conditions.
Clinical trials examining new treatments for severe asthma and related respiratory conditions. Studies are evaluating novel medications and delivery systems to improve symptom control and reduce exacerbations.
Research emphasizes both immediate symptom relief and long-term disease control.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
